Ro24-7429

CAT:
804-HY-19149-01
Size:
5 mg
  • Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
  • Dry Ice Shipment: No
Ro24-7429 - image 1

Ro24-7429

  • Description:

    Ro24-7429 is a potent and orally active HIV-1 transactivator protein Tat antagonist. Ro24-7429 is also a runt-related transcription factor 1 (RUNX1) inhibitor. Ro24-7429 has anti-HIV, antifibrotic and anti-inflammatory effects[1][2].
  • UNSPSC:

    12352005
  • Hazard Statement:

    H302, H315, H319, H335
  • Target:

    Apoptosis; HIV
  • Type:

    Reference compound
  • Related Pathways:

    Anti-infection; Apoptosis
  • Applications:

    COVID-19-anti-virus
  • Field of Research:

    Cancer; Infection; Inflammation/Immunology
  • Assay Protocol:

    https://www.medchemexpress.com/ro24-7429.html
  • Concentration:

    10mM
  • Purity:

    99.85
  • Solubility:

    DMSO : 62.5 mg/mL (ultrasonic)
  • Smiles:

    CNC1=NC2=CC=C(Cl)C=C2C(C3=CC=CN3)=NC1
  • Molecular Formula:

    C14H13ClN4
  • Molecular Weight:

    272.73
  • Precautions:

    H302, H315, H319, H335
  • References & Citations:

    [1]A H Patki, et al. HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors. Cell Immunol. 1996 Apr 10;169 (1) :40-6.|[2]Michael O'Hare, et al. Targeting Runt-Related Transcription Factor 1 Prevents Pulmonary Fibrosis and Reduces Expression of Severe Acute Respiratory Syndrome Coronavirus 2 Host Mediators. Am J Pathol. 2021 Jul;191 (7) :1193-1208.
  • Shipping Conditions:

    Room Temperature
  • Storage Conditions:

    -20°C, 3 years; 4°C, 2 years (Powder)
  • Scientific Category:

    Reference compound1
  • Clinical Information:

    No Development Reported
  • Isoform:

    HIV-1
  • CAS Number:

    [139339-45-0]